CORC

浏览/检索结果: 共18条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia 期刊论文
Alzheimer's Research & Therapy, 2021, 卷号: 13, 期号: 1
作者:  Xiao,Shifu;  Chan,Piu;  Wang,Tao;  Hong,Zhen;  Wang,Shuzhen
收藏  |  浏览/下载:147/0  |  提交时间:2021/05/24
Functional Connectivity of Anterior Insula Predicts Recovery of Patients With Disorders of Consciousness 期刊论文
FRONTIERS IN NEUROLOGY, 2018, 卷号: 9, 页码: 10
作者:  Zhang, Li;  Luo, Lunjie;  Zhou, Zhen;  Xu, Kaibin;  Zhang, Lijuan
收藏  |  浏览/下载:47/0  |  提交时间:2019/07/12
The cost of Alzheimer's disease in China and re-estimation of costs worldwide 期刊论文
ALZHEIMERS & DEMENTIA, 2018, 卷号: 14, 期号: 4
作者:  Jia, Jianping;  Wei, Cuibai;  Chen, Shuoqi;  Li, Fangyu;  Tang, Yi
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
The cost of Alzheimer's disease in China and re-estimation of costs worldwide 期刊论文
ALZHEIMERS & DEMENTIA, 2018, 卷号: 14, 期号: 4
作者:  Guo, Qihao;  Qu, Qiumin;  Yang, Shanshan;  Wang, Yanjiang;  Luo, Benyan
收藏  |  浏览/下载:34/0  |  提交时间:2019/12/05
The cost of Alzheimer's disease in China and re-estimation of costs worldwide 期刊论文
Alzheimer's & dementia : the journal of the Alzheimer's Association, 2018, 卷号: 14, 期号: 4, 页码: 483-491
作者:  Jia, Jianping*;  Wei, Cuibai*;  Chen, Shuoqi;  Li, Fangyu;  Tang, Yi
收藏  |  浏览/下载:29/0  |  提交时间:2019/12/03
The cost of Alzheimer's disease in China and re-estimation of costs worldwide 期刊论文
ALZHEIMERS & DEMENTIA, 2018, 卷号: 14, 页码: 483-491
作者:  Jia, Jianping;  Wei, Cuibai;  Chen, Shuoqi;  Li, Fangyu;  Tang, Yi
收藏  |  浏览/下载:24/0  |  提交时间:2019/11/26
The cost of Alzheimer's disease in China and re-estimation of costs worldwide 期刊论文
ALZHEIMERS & DEMENTIA, 2018, 卷号: 14, 期号: 4
作者:  Jia, Jianping;  Wei, Cuibai;  Chen, Shuoqi;  Li, Fangyu;  Tang, Yi
收藏  |  浏览/下载:47/0  |  提交时间:2019/12/05
Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial 期刊论文
AGE AND AGEING, 2017, 卷号: 46, 期号: 5
作者:  Xiao, Shifu;  Wang, Tao;  Ma, Xiuqiang;  Qin, Yingyi;  Li, Xia
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/04
Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial 期刊论文
AGE AND AGEING, 2017, 卷号: 46, 期号: 5
作者:  Li, Xia;  He, Jia;  Hou, Deren;  Ma, Qilin;  Wu, Lan
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial 期刊论文
Age and Ageing, 2017, 卷号: 46, 期号: 5, 页码: 767-773
作者:  Xiao, Shifu;  Wang, Tao;  Ma, Xiuqiang;  Qin, Yingyi;  Li, Xia
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/03


©版权所有 ©2017 CSpace - Powered by CSpace